Jerry Chang

President
FaceHeart Corporation
​
​
​`

Jerry Chang is the President of FaceHeart Corporation, an AI technology and digital health innovator dedicated to making health monitoring accessible and proactive. The company’s flagship solution—a Contactless Single-Camera Video-Based Vital Sign Measurement System—embodies its mission: “Connect AI from Face to Heart.” Under Jerry’s leadership, FaceHeart is advancing into the Smart Health era, shaping one of the most promising technology frontiers of the next decade.
With over 30 years of experience across telecommunications, software, and venture capital, Jerry brings visionary leadership and technical depth to the health tech sector.
Career Highlights:
President, FaceHeart (2018–Present)
Leading development of AI-powered digital health platforms for B2B and SaaS markets.
Freelance Consultant for high-tech firms in the U.S. and Asia-Pacific.
Founder & CEO, Mobile Diameters, Inc. (2010–2014)
Delivered mobile payment solutions to telecom and financial sectors.
Venture Partner (2005–2009)
Managed investments in software and telecom startups in Silicon Valley.
Founder & CEO, Mobile Radius, Inc. (2002–2004)
Provided BSS solutions for wireless telecom operators.
Serial Entrepreneur
Co-founded and led a startup to IPO on NASDAQ in 1999.Industry Impact:
Pioneer in the VoIP industry.
Long-term collaborations with global telecom giants, including AT&T, NTT, China Mobile, SK Telecom, and Telstra.
Holder of multiple technology patents.
Early career roles at Intel, Unisys, Gupta Technologies, and Software Publishing (12+ years).Education & Recognition:
M.S. in Computer Science, Pennsylvania State University
B.S. in Control Engineering, National Chiao-Tung University, Taiwan
Recipient of the Outstanding Alumni Award from NCTU (2001)​

Speech title & Synopsis

Company Profile

FaceHeart Vitals™ is an AI-powered software solution that enables contactless, real-time vital sign monitoring using a single standard camera. Developed by FaceHeart Corporation, this Software as a Medical Device (SaMD) utilizes proprietary remote photoplethysmography (rPPG) algorithms and deep learning to extract physiological signals from subtle facial color changes—without any wearables or physical contact.
FDA-Cleared Technology
FaceHeart Vitals™ is the world’s first dual-cleared purely vision-based vital sign measurement software. It has received two U.S. FDA 510(k) clearances:
K223622 – Heart Rate Monitoring
K243966 – Respiratory Rate MonitoringThese approvals validate the software’s safety and accuracy for clinical use, marking a major breakthrough in digital health innovation.
Key Vital Signs Measured:
Heart Rate (HR) – FDA cleared
Respiration Rate (RR) – FDA cleared
Blood Oxygen Saturation (SpO₂)
Blood Pressure (SBP/DBP)
Heart Rate Variability (HRV)
Stress Index
Atrial fibrillation (Afib)Core Advantages:
Contactless & Non-Intrusive: No devices to wear or touch—just a camera.
Real-Time Results: Vital signs detected within 50 seconds.
Multi-Platform Compatibility: Android, iOS, Windows, Linux; adaptable to various chipsets and edge devices.
Scalable Integration: SDK/API available for seamless B2B deployment.Application Scenarios:
Smart Health & Wellness: Daily health tracking for consumers.
Telemedicine: Remote physiological monitoring to support clinical decisions.
Insurance & Risk Assessment: AI-powered health scoring for underwriting.
Corporate Health & Safety: Fatigue and stress detection in workplaces.
Public Health Surveillance: Crowd-level monitoring in schools, transport, or venues.By combining computer vision, AI, and medical-grade signal processing, FaceHeart Vitals™ transforms ordinary cameras into powerful health sensing tools. As demand for non-contact, preventive, and remote healthcare solutions grows, FaceHeart Vitals™ is set to become a cornerstone technology in next-generation smart health ecosystems.